← Open Payments lookup

PETRA GUILMAIN: Open Payments

NPI 1831723881 · HAMBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,958 in 267 payments from 20 companies in 2025. Trend: 2023 $3,481 · 2024 $4,237 · 2025 $5,958

Food & beverage: $4,888Travel & lodging: $1,070
CompanyPaymentsAmount
ABBVIE INC.61$1,221
Neuronetics, Inc.3$1,194
Otsuka America Pharmaceutical, Inc.29$592
Neurocrine BioSciences, Inc.17$434
Teva Pharmaceuticals USA, Inc.26$357
Lundbeck LLC27$356
Janssen Pharmaceuticals, Inc12$296
Axsome Therapeutics, Inc.22$262
Vanda Pharmaceuticals Inc.7$246
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$246

Products named: VRAYLAR, NEUROSTAR TMS THERAPY SYSTEM, REXULTI, INGREZZA, SPRAVATO, Auvelity, FANAPT, CAPLYTA.

Industry payments across NY — which companies pay providers there.